References
Key articles
Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-421.Full text Abstract
Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.Full text Abstract
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133.Full text Abstract
Reference articles
1. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343-421.Full text Abstract
2. Hamburger JI, Taylor CI. Transient thyrotoxicosis associated with acute hemorrhagic infarction of autonomously functioning thyroid nodules. Ann Intern Med. 1979 Sep;91(3):406-9. Abstract
3. Cooper DS. Hyperthyroidism. Lancet. 2003 Aug 9;362(9382):459-68. Abstract
4. Corvilain B. The natural history of thyroid autonomy and hot nodules. Ann Endocrinol (Paris). 2003;64:17-22. Abstract
5. De Leo S, Lee SY, Braverman LE. Hyperthyroidism. Lancet. 2016 Aug 27;388(10047):906-18.Full text Abstract
6. Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015 Jul;25(7):716-59.Full text Abstract
7. Brtko J, Bobalova J, Podoba J, et al. Thyroid hormone receptors and type I iodothyronine 5'-deiodinase activity of human thyroid toxic adenomas and benign cold nodules. Exp Clin Endocrinol Diabetes. 2002 Jun;110(4):166-70. Abstract
8. Krohn K, Führer D, Holzapfel HP, et al. Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations. J Clin Endocrinol Metab. 1998 Jan;83(1):130-4. Abstract
9. Führer D. Constitutive TSH receptor activation as a hallmark of thyroid autonomy. Endocrine. 2020 May;68(2):274-8.Full text Abstract
10. Derwahl M. TSH receptor and Gs-alpha gene mutations in the pathogenesis of toxic thyroid adenomas - a note of caution. J Clin Endocrinol Metab. 1996 Aug;81(8):2783-5. Abstract
11. Krohn K, Fuhrer D, Bayer Y, et al. Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev. 2005 Jun;26(4):504-24. Abstract
12. Bartalena L, Bogazzi F, Chiovato L, et al. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018 Mar;7(2):55-66.Full text Abstract
13. Morris AJ, Malbon CC. Physiological regulation of G protein-linked signaling. Physiol Rev. 1999 Oct;79(4):1373-430. Abstract
14. Poertl S, Kirner J, Saller B, et al. T3-release from autonomously functioning thyroid nodules in vitro. Exp Clin Endocrinol Diabetes. 1998;106(6):489-93. Abstract
15. Polak M. Hyperfunctioning thyroid adenoma and activating mutations in the TSH receptor gene. Arch Med Res. 1999 Nov-Dec;30(6):510-3. Abstract
16. Derwahl M, Hamacher C, Russo D, et al. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. J Clin Endocrinol Metab. 1996 May;81(5):1898-904. Abstract
17. Tonacchera M, Vitti P, De Servi M, et al. Gain of function TSH receptor mutations and iodine deficiency: implications in iodine prophylaxis. J Endocrinol Invest. 2003;26(2 suppl):2-6. Abstract
18. Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015 Apr;3(4):286-95. Abstract
19. Fiore E, Tonacchera M, Vitti P. Influence of iodization programmes on the epidemiology of nodular goitre. Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):577-88. Abstract
20. Maniakas A, Davies L, Zafereo ME. Thyroid disease around the world. Otolaryngol Clin North Am. 2018 Jun;51(3):631-42. Abstract
21. Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.Full text Abstract
22. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133.Full text Abstract
23. Scappaticcio L, Longo M, Maiorino MI, et al. Abnormal liver blood tests in patients with hyperthyroidism: systematic review and meta-analysis. Thyroid. 2021 Jun;31(6):884-94.Full text Abstract
24. Scappaticcio L, Maiorino MI, Maio A, et al. Neutropenia in patients with hyperthyroidism: systematic review and meta-analysis. Clin Endocrinol (Oxf). 2021 Mar;94(3):473-83. Abstract
25. Thiruvengadam S, Luthra P. Thyroid disorders in elderly: a comprehensive review. Dis Mon. 2021 Nov;67(11):101223. Abstract
26. Kakuno Y, Amino N, Kanoh M, et al. Menstrual disturbances in various thyroid diseases. Endocr J. 2010;57(12):1017-22.Full text Abstract
27. Gorenek B, Boriani G, Dan GA, et al. European Heart Rhythm Association (EHRA) position paper on arrhythmia management and device therapies in endocrine disorders, endorsed by Asia Pacific Heart Rhythm Society (APHRS) and Latin American Heart Rhythm Society (LAHRS). Europace. 2018 Jun 1;20(6):895-6.Full text Abstract
28. Intenzo CM, dePapp AE, Jabbour S, et al. Scintigraphic manifestations of thyrotoxicosis. Radiographics. 2003 Jul-Aug;23(4):857-69. Abstract
29. Baldini M, Orsatti A, Cantalamessa L. A singular case of Graves' disease in congenital thyroid hemiagenesis. Horm Res. 2005;63(3):107-10. Abstract
30. US Preventive Services Task Force. Thyroid dysfunction: screening. Jul 2015 [internet publication].Full text
31. Garber JR, Papini E, Frasoldati A, et al. American Association of Clinical Endocrinology and Associazione Medici Endocrinologi thyroid nodule algorithmic tool. Endocr Pract. 2021 Jul;27(7):649-60.Full text Abstract
32. American College of Radiology. ACR appropriateness criteria. Thyroid disease. 2018 [internet publication].Full text
33. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017 Mar;27(3):315-89.Full text Abstract
34. Tankeu AT, Azabji-Kenfack M, Nganou CN, et al. Effect of propranolol on heart rate variability in hyperthyroidism. BMC Res Notes. 2018 Feb 22;11(1):151.Full text Abstract
35. Ross DS. Radioiodine therapy for hyperthyroidism. N Engl J Med. 2011 Feb 10;364(6):542-50. Abstract
36. Tarantini B, Ciuoli C, DiCairano G, et al. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism. J Endocrinol Invest. 2006 Jul-Aug;29(7):594-8. Abstract
37. Erdogan MF, Kucuk NO, Anil C, et al. Effect of radioiodine therapy on thyroid nodule size and function in patients with toxic adenomas. Nucl Med Commun. 2004 Nov;25(11):1083-7. Abstract
38. Nygaard B, Hegedus L, Nielsen KG, et al. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules. Clin Endocrinol (Oxf). 1999 Feb;50(2):197-202. Abstract
39. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012 Aug;97(8):2543-65.Full text Abstract
40. Morales DR, Fonkwen L, Nordeng HME. Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations. Br J Clin Pharmacol. 2021 Oct;87(10):3890-900.Full text Abstract
41. Biondi B, Cooper DS. Subclinical hyperthyroidism. N Engl J Med. 2018 Jun 21;378(25):2411-9. Abstract
42. Evron JM, Papaleontiou M. Decision making in subclinical thyroid disease. Med Clin North Am. 2021 Nov;105(6):1033-45. Abstract
43. Pearce EN. Diagnosis and management of thyrotoxicosis. BMJ. 2006 Jun 10;332(7554):1369-73. Abstract
44. Reid JR, Wheeler SF. Hyperthyroidism: diagnosis and treatment. Am Fam Physician. 2005 Aug 15;72(4):623-30. Abstract
45. Cooper DS. Antithyroid drugs. N Engl J Med. 2005 Mar 3;352(9):905-17. Abstract
46. Karras S, Tzotzas T, Krassas GE. Antithyroid drugs used in the treatment of hyperthyroidism during breast feeding. An update and new perspectives. Hormones (Athens). 2009 Oct-Dec;8(4):254-7. Abstract
47. Stan MN, Papaleontiou M, Schmitz JJ, et al. Nonsurgical management of thyroid nodules: the role of ablative therapies. J Clin Endocrinol Metab. 2022 Apr 19;107(5):1417-30.Full text Abstract
48. Barile A, Quarchioni S, Bruno F, et al. Interventional radiology of the thyroid gland: critical review and state of the art. Gland Surg. 2018 Apr;7(2):132-46.Full text Abstract
49. Muhammad H, Tehreem A, Russell JO, et al. Radiofrequency ablation and autonomous functioning thyroid nodules: review of the current literature. Laryngoscope. 2022 Apr;132(4):906-14. Abstract
50. Ha EJ, Baek JH, Kim KW, et al. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab. 2015 May;100(5):1903-11. Abstract
51. American College of Radiology, American College of Nuclear Medicine, American Society for Radiation Oncology, Society of Nuclear Medicine and Molecular Imaging, Society for Pediatric Radiology. Practice parameter for treatment of benign and malignant thyroid disease with I-131 sodium iodide. 2019 [internet publication].Full text
52. American Thyroid Association Taskforce On Radioiodine Safety, Sisson JC, Freitas J, et al. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association. Thyroid. 2011 Apr;21(4):335-46. Abstract
53. Hegedüs L. Clinical practice. The thyroid nodule. N Engl J Med. 2004 Oct 21;351(17):1764-71. Abstract
54. Ceccarelli C, Bencivelli W, Vitti P, et al. Outcome of radioiodine-131 therapy in hyperfunctioning thyroid nodules: a 20 years’ retrospective study. Clin Endocrinol (Oxf). 2005 Mar;62(3):331-5. Abstract
55. Delitala AP, Scuteri A, Doria C. Thyroid hormone diseases and osteoporosis. J Clin Med. 2020 Apr 6;9(4):1034.Full text Abstract
56. Franklyn JA, Boelaert K. Thyrotoxicosis. Lancet. 2012 Mar 24;379(9821):1155-66. Abstract
57. Tzavara I, Tzanela M, Vlassopoulou B, et al. Long term thyroid function after (131)I treatment for toxic adenoma. Hormones (Athens). 2002 Apr-Jun;1(2):99-103. Abstract
Use of this content is subject to our disclaimer